Current Edition

Aragen

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide-ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base Aragen Life Sciences (formerly, GVK BIO), a leading …

Continue Reading →
biotech

Immuno-oncology CRO secures Macrophage Pharma agreement

Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech …

Continue Reading →